Golodirsen
Composition
This Formulation contains Golodirsen as a active pharmaceutical ingrediant
Indications
Golodirsen is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients with a confirmed mutation amenable to exon 53 skipping.
Side effects
Common side effects include headache, pyrexia (fever), cough, vomiting
Precautions
cautiosly used in patients having renal impairment.
Contraindications
Contraindicated in patients those who have serious hypersensitivity towards Golodirsen
Dosage and administration
30 mg once in a week through IV infusion
Countries
Unites states
Available Forms
Solution for IV infusion
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai